Pathoetiology of Levator Ani Syndrome and Its Treatment With Translumbosacral Neuromodulation Therapy

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

INTRODUCTION:The pathoetiology and treatment of levator ani syndrome (LAS) remain unclear.METHODS:We evaluated pathophysiology using translumbosacral motor-evoked potentials and anorectal manometry in patients with LAS and compared with healthy controls. A cohort underwent translumbosacral neuromodulation therapy (TNT).RESULTS:Lumbar and sacral motor-evoked potential latencies were prolonged in 32 patients with LAS compared with 31 controls (P < 0.013), with higher prevalence of anal neuropathy (P = 0.026). TNT improved anorectal pain (P = 0.003) and neuropathy (P < 0.02) in 13 patients with LAS.DISCUSSION:Patients with LAS demonstrate significant lumbosacral neuropathy that may cause anorectal pain. TNT improved anorectal pain and neuropathy, providing a novel therapeutic option.

Original languageEnglish (US)
Pages (from-to)2242-2246
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume118
Issue number12
DOIs
StatePublished - Dec 1 2023
Externally publishedYes

Keywords

  • TAMS
  • anorectal
  • levator ani syndrome
  • neuromodulation therapy
  • neuropathy

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint

Dive into the research topics of 'Pathoetiology of Levator Ani Syndrome and Its Treatment With Translumbosacral Neuromodulation Therapy'. Together they form a unique fingerprint.

Cite this